TrialNature medicine2025
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
Jerry R Mendell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
93 papers cite itlatest 60 shown
this paperpooled ittrialcites it